Actinium therapy, a radioactive isotope that emits alpha particles, is used in targeted cancer treatment. This treatment is particularly used for certain types of cancer, such as prostate cancer. Also known as alpha therapy, it is a treatment method based on the principle of directing a radioactive substance directly at cancer cells and destroying them without harming surrounding healthy tissues.
Revolutionary advances in cancer treatment are constantly attracting the attention of the medical community. One of these innovations is Actinium-225 (Ac-225) therapy, which is particularly promising in the field of targeted radionuclide therapy. Actinium treatment is performed at Lifemed advanced imaging, diagnosis and treatment center. You can contact us to benefit from this treatment.
Advantages of Actinium-225 Treatment
Potential Side Effects of Actinium-225 Therapy
Like any medical treatment, Actinium-225 treatment has some potential side effects. These may include nausea, fatigue, decreased blood cells and increased dry mouth. However, the severity and frequency of these side effects may vary depending on the condition of the patient being treated and the type of cancer being treated.
Actininium-225 Treatment for Prostate Cancer
Actinium-225 PSMA therapy can be used in metastatic and castration-resistant prostate cancer. Castration-resistant disease is defined as progression of the disease despite a serum testrn level compatible with castration. The treatment decision is made by the patient's attending physician. Actinium-225 therapy is seen as a significant advance in cancer treatment and research in this area is ongoing. The results of clinical trials are awaited to learn more about the efficacy and safety of the treatment.
Bilgilendirme amaçlıdır.
